- Home
- CPHC vs ARMP Comparison
CPHC vs ARMP Comparison
Compare CPHC & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHC
- ARMP
- Stock Information
- Founded
- CPHC 1994
- ARMP N/A
- Country
- CPHC United States
- ARMP United States
- Employees
- CPHC N/A
- ARMP N/A
- Industry
- CPHC Services-Misc. Amusement & Recreation
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPHC Consumer Discretionary
- ARMP Health Care
- Exchange
- CPHC Nasdaq
- ARMP Nasdaq
- Market Cap
- CPHC 92.5M
- ARMP 92.4M
- IPO Year
- CPHC 1994
- ARMP N/A
- Fundamental
- Price
- CPHC $16.85
- ARMP $2.56
- Analyst Decision
- CPHC
- ARMP Strong Buy
- Analyst Count
- CPHC 0
- ARMP 1
- Target Price
- CPHC N/A
- ARMP $9.00
- AVG Volume (30 Days)
- CPHC 1.9K
- ARMP 8.9K
- Earning Date
- CPHC 08-07-2025
- ARMP 08-12-2025
- Dividend Yield
- CPHC 1.67%
- ARMP N/A
- EPS Growth
- CPHC N/A
- ARMP N/A
- EPS
- CPHC 0.03
- ARMP N/A
- Revenue
- CPHC $60,069,270.00
- ARMP $6,868,000.00
- Revenue This Year
- CPHC N/A
- ARMP $8.43
- Revenue Next Year
- CPHC N/A
- ARMP N/A
- P/E Ratio
- CPHC $568.75
- ARMP N/A
- Revenue Growth
- CPHC N/A
- ARMP 84.67
- 52 Week Low
- CPHC $16.15
- ARMP $0.90
- 52 Week High
- CPHC $22.93
- ARMP $2.96
- Technical
- Relative Strength Index (RSI)
- CPHC 39.87
- ARMP 54.07
- Support Level
- CPHC $16.15
- ARMP $2.44
- Resistance Level
- CPHC $16.83
- ARMP $2.65
- Average True Range (ATR)
- CPHC 0.27
- ARMP 0.16
- MACD
- CPHC -0.04
- ARMP -0.01
- Stochastic Oscillator
- CPHC 32.43
- ARMP 55.56
About CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.